| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976760 | Brachytherapy | 2012 | 5 Pages |
Abstract
In this study of patients with low and intermediate risk of prostate cancer, comparable outcomes at 5 years were noted between modalities with increased costs associated with IMRT.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chirag Shah, Thomas B. Jr., Mihai I. Ghilezan, Gary S. Gustafson, Kimberly S. Marvin, Hong Ye, Frank A. Vicini, Alvaro A. Martinez,